R. Daniel Beauchamp

13.7k total citations · 3 hit papers
179 papers, 11.4k citations indexed

About

R. Daniel Beauchamp is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, R. Daniel Beauchamp has authored 179 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 77 papers in Oncology and 35 papers in Pathology and Forensic Medicine. Recurrent topics in R. Daniel Beauchamp's work include TGF-β signaling in diseases (34 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Genetic factors in colorectal cancer (31 papers). R. Daniel Beauchamp is often cited by papers focused on TGF-β signaling in diseases (34 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Genetic factors in colorectal cancer (31 papers). R. Daniel Beauchamp collaborates with scholars based in United States, Australia and Japan. R. Daniel Beauchamp's co-authors include Hongmiao Sheng, Robert J. Coffey, Jason D. Morrow, Jian‐Hua Shao, Raymond N. DuBois, R.N. Dubois, Pran K. Datta, Jinyi Shao, Harold L. Moses and Yu Shyr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

R. Daniel Beauchamp

176 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

1998 986 citations Hongmiao Sheng, Jian‐Hua Shao et al. profile →
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1997 627 citations Hongmiao Sheng, Jian‐Hua Shao et al. Journal of Clinical Investigation profile →
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

2009 562 citations J. Joshua Smith, Natasha G. Deane et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Daniel Beauchamp United States	61	5.1k	3.9k	2.4k	2.1k	2.0k	179	11.4k
Ari Ristimäki Finland	54	4.1k 0.8×	3.0k 0.8×	3.2k 1.3×	2.0k 1.0×	2.5k 1.2×	197	10.6k
Masanobu Oshima Japan	56	6.9k 1.4×	4.3k 1.1×	3.1k 1.3×	2.8k 1.3×	2.8k 1.4×	154	14.3k
Gabriella Ferrandina Italy	63	4.6k 0.9×	4.8k 1.3×	760 0.3×	2.0k 0.9×	1.2k 0.6×	496	15.8k
Masahiko Tsujii Japan	45	2.8k 0.5×	2.0k 0.5×	5.8k 2.4×	1.8k 0.9×	3.4k 1.7×	198	11.6k
Frank A. Sinicrope United States	66	4.4k 0.9×	7.4k 1.9×	1.4k 0.6×	2.8k 1.3×	920 0.5×	249	13.3k
Powel H. Brown United States	54	5.2k 1.0×	3.9k 1.0×	652 0.3×	2.6k 1.3×	2.3k 1.1×	223	10.1k
Steven M. Dubinett United States	63	3.6k 0.7×	4.8k 1.2×	2.7k 1.1×	1.9k 0.9×	1.4k 0.7×	211	12.7k
John D. Schuetz United States	74	6.6k 1.3×	10.9k 2.8×	700 0.3×	1.2k 0.6×	1.2k 0.6×	196	19.4k
Stimson P. Schantz United States	49	3.1k 0.6×	2.3k 0.6×	455 0.2×	1.5k 0.7×	1.0k 0.5×	162	8.1k
Sunao Kawano Japan	39	1.8k 0.3×	1.1k 0.3×	3.3k 1.4×	1.0k 0.5×	1.9k 1.0×	121	7.6k

Countries citing papers authored by R. Daniel Beauchamp

Since Specialization

Citations

This map shows the geographic impact of R. Daniel Beauchamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Daniel Beauchamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Daniel Beauchamp more than expected).

Fields of papers citing papers by R. Daniel Beauchamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Daniel Beauchamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Daniel Beauchamp. The network helps show where R. Daniel Beauchamp may publish in the future.

Co-authorship network of co-authors of R. Daniel Beauchamp

This figure shows the co-authorship network connecting the top 25 collaborators of R. Daniel Beauchamp. A scholar is included among the top collaborators of R. Daniel Beauchamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Daniel Beauchamp. R. Daniel Beauchamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jing, James S. Lewis, Thomas Andl, et al.. (2024). Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma. The Journal of Pathology. 264(1). 4–16. 3 indexed citations

Wang-Bishop, Lihong, Zheng Chen, A. Craig Lockhart, et al.. (2018). Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Gastroenterology. 156(3). 662–675.e7. 71 indexed citations

González, Raul S., Won Jae Huh, Justin Cates, et al.. (2016). Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial–mesenchymal transition. Histopathology. 70(2). 223–231. 28 indexed citations

Ma, Yufang, Lihong Wang, Leif R. Neitzel, et al.. (2016). The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer. Clinical Cancer Research. 23(8). 2027–2037. 56 indexed citations

Tripathi, Manish K., Natasha G. Deane, Jing Zhu, et al.. (2014). Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer. Cancer Research. 74(23). 6947–6957. 98 indexed citations

Hansen, Amanda G., Tanner J. Freeman, Shanna A. Arnold, et al.. (2013). Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome. Cancer Research. 73(10). 2955–2964. 36 indexed citations

Pope, Jillian L., Ajaz A. Bhat, Ashok Sharma, et al.. (2013). Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut. 63(4). 622–634. 202 indexed citations

Barrett, Caitlyn W., J. Joshua Smith, Nicholas O. Markham, et al.. (2012). Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters. PLoS ONE. 7(12). e51205–e51205. 20 indexed citations

Oh, Sang Cheul, Yun‐Yong Park, Eun Sung Park, et al.. (2011). Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. Gut. 61(9). 1291–1298. 64 indexed citations

10.

Nam, Ki Taek, J. Joshua Smith, Lynne A. Lapierre, et al.. (2010). Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. Journal of Clinical Investigation. 120(3). 840–849. 118 indexed citations

11.

Xu, Baogang, Jiaqing Li, R. Daniel Beauchamp, et al.. (2009). Identification of Early Intestinal Neoplasia Protein Biomarkers Using Laser Capture Microdissection and MALDI MS. Molecular & Cellular Proteomics. 8(5). 936–945. 19 indexed citations

12.

Smith, J. Joshua, Christian Kis, Carl Schmidt, et al.. (2008). Oncogenic Ras and Transforming Growth Factor-β Synergistically Regulate AU-Rich Element–Containing mRNAs during Epithelial to Mesenchymal Transition. Molecular Cancer Research. 6(7). 1124–1136. 28 indexed citations

13.

Xu, Baogang, Bashar Shakhtour, Natasha G. Deane, et al.. (2007). Variability of in situ proteomic profiling and implications for study design in colorectal tumors. International Journal of Oncology. 31(1). 103–11. 6 indexed citations

14.

Townsend, Courtney M., R. Daniel Beauchamp, Bastiaan Evers, & Kenneth L. Mattox. (2004). Sabiston textbook of surgery 17th edition board review. Elsevier eBooks. 3 indexed citations

15.

Ko, Tien C., et al.. (1998). Cyclin D3 is essential for intestinal epithelial cell proliferation. Gastroenterology. 114. A1401–A1401. 1 indexed citations

16.

Sheng, Hongmiao, Jian‐Hua Shao, Susan C. Kirkland, et al.. (1997). Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.. Journal of Clinical Investigation. 99(9). 2254–2259. 627 indexed citations breakdown →

17.

Sumi, Shoichiro, et al.. (1994). Lovastatin Inhibits Pancreatic Cancer Growth Regardless of RAS Mutation. Pancreas. 9(5). 657–661. 48 indexed citations

18.

Beauchamp, R. Daniel, William H. Nealon, Courtney M. Townsend, & J. C. Thompson. (1985). Cholecystokinin-stimulated pancreatic secretion is inhibited by proglumide. 36. 177–180. 1 indexed citations

19.

Greeley, George H., et al.. (1985). Authentic neurotensin is present in the circulation during fat ingestion in dogs. 36. 58–60. 1 indexed citations

20.

Beauchamp, R. Daniel, et al.. (1977). Total replacement arthroplasty of elbow in rheumatoid arthritis.. VocBench (University of Rome Tor Vergata). 20(3). 234–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact